ABSTRACT Objective: To describe the course of migraine without aura and migraine with aura during pregnancy and factors that could influence its course, among migraine sufferers before pregnancy. Method: A cross sectional study undertaken at the IMIP, Brazil. Out of 686 consecutively assisted women, at the first postnatal week, 266 were identified as migraine sufferers before pregnancy. Results: There was migraine remission in 35.4%, 76.8% and 79.3% among migraine without aura sufferers and 20.7%, 58.6% and 65.5% among those with migraine with aura, respectively in the first, second and third trimesters. Statistically significant difference was found when the first trimester was compared with the second and third trimesters. The factors associated with the presence of migraine during pregnancy were: multiparity, menstrually related migraine without aura prior to pregnancy and illness during pregnancy. Conclusion: The study contributed to elucidate the course of migraine during pregnancy in migraine sufferers prior to pregnancy. Key words: migraine without aura, migraine with aura, pregnancy.
Migraine is one of the most common neurological disorders among women, with a female/male proportion of 3-4:1 1 . Its prevalence among women varies from 4% before puberty to 25% during the reproductive life, decreasing later in perimenopause and post-menopause 1 . One knows that migraine behavior during women's reproductive life is influenced by cyclical fluctuations in sex hormones [2] [3] [4] , with attacks that occur predominantly during the menstrual period 4, 5 . Changes in migraine frequency can also occur during pregnancy, lactation 6 and contraceptive use 2 . The hypothalamic-pituitary-ovarian axes regulates hormonal fluctuations associated to the menstrual cycle 7 and the abrupt decline in estrogen seems to play a key role in triggering menstrual migraine 8 . This also occurs during the week of hormonal suspension in women that use combined oral contraceptives 9 and in the immediate postpartum period 10 , what could explain the increase in migraine attacks during these periods 3 . During pregnancy, the frequency of migraine decreases in most women, with an increase in its remission from the first to the third trimester 6 . One of the explanations for these findings is the increased levels of estrogen in the first trimester and a tendency to stability during the second and third trimesters of pregnancy 3 . The aim of the present study is to describe the course of with and without aura migraine during pregnancy, in a group of migraine sufferers before pregnancy, as well as associated factors that could influence its course.
METHOD
It is a retrospective study undertaken at the Breast Milk Bank (BMB) of the Instituto de Medicina Integral Professor Fernando Figueira (IMIP) in Recife PE, Brazil, for a period of six months.
A questionnaire was applied to all women assisted, around the eighth postpartum day (between the seventh and the tenth day), for the first postnatal visit at the Outpatient Clinic of the BMB/IMIP, that had given birth in the Maternity Unit of the Institution, after signing the Consent Form. So, there was no bias in the sample selection, given the fact that all women were consecutively enrolled in the study.
The data collection form included questions related to socioeconomic (maternal education, per capita income, maternal age, race/skin color, marital status, occupation), obstetric (number of pregnancies and diseases during pregnancy) and biological factors (migraine without aura -MO before pregnancy and migraine with aura -MA before pregnancy, related or not to tension type headache -TTH before pregnancy and family history of migraine).
MO and MA sufferers before pregnancy, classified according to the International Classification of Headache Disorders (ICHD-2004) 11 , were included in the sample. Postpartum women with neurological diseases that could characterize secondary headache and those that disagreed in taking part in the study would form the exclusion group.
Although the definition of pure menstrual migraine and menstrually related migraine refers only to MO 11 , we called menstrually related migraine, those that occurred only during the menstrual cycle as well as those that also occurred outside it, in both MO and MA cases. The two categories were grouped in view of the difficulties of a retrospective identification, due to the fact that the questionnaire was applied in the postpartum period.
Independent variables that constitute risk or protection factors, according to the literature 6 , for the presence of migraine attacks during pregnancy, were selected. Socioeconomic and demographic factors formed the first block of variables (maternal education, per capita income, maternal age, race/color of the skin). The second block included variables related to obstetric factors (number of pregnancies and diseases during pregnancy) and the third block included biological factors related to migraine and headache history in the family. The outcome was represented by the presence of migraine attacks in the first or second or third trimester of pregnancy.
The statistical significance of each variable was calculated using the Wald test for heterogeneity. The bivariate analysis allowed to identify the explanatory variables considering as screening criteria the associations with p<0.20. Next, a multivariate analysis using Poisson multiple regression with robust standard error was performed, the adjusted prevalence ratios were estimated, their respective 95% confidence intervals and the statistical significance, adopting a p≤0.05, using the same tests described before. To compare the trimesters with the occurrence of migraine attacks during pregnancy, the had menstrually related migraine before pregancy, most of them (87.8) were MO patients and only 12.2% were MA sufferers. Most of the women had finished high school (75.5%) and were poor, with a per capita income less than half the national minimum wage (70.7%). The mean age was 27 years, they reported themselves as black/colored (70.7%), were married or had a consensual union (85.8%), did not work (60.2%) and were primigravids (59.4 %). The majority of them had vaginal deliveries (66.2%). Eightythree women (31.2%) had diseases during pregnancy. Of these, 60 (22.6%) had hypertension, 21 (7.9%) diabetes and 17 (6.4%) urinary tract infection. High blood pressure was the only disease that showed a statistically sig-nificant association (chi-square) with migraine attacks in the second (p=0.004) and third (p<0.001) trimester of pregnancy. As diagnoses were retrospective one was unable to specify which type of hypertension or diabetes women had during pregnancy.
None of the women experiencing remission during the first and second trimester of pregnancy showed migraine attacks in the third trimester. Fifty nine women continued to have migraine attacks during all the gestation period. Table 1 shows a statistically significant difference between the frequency of MO and MA in the first trimester, compared with the second and third trimester of pregnancy among MO and MA sufferers before pregnancy. There was no statistical difference in migraine frequencies between the second and third trimester of pregnancy in relation to MO and MA sufferers, respectively, p=0.210 and p=0.500.
Among the 59 women that had TTH associated with MO or MA before pregnancy, there was also a statistically significant difference when the presence of TTH in the first trimester 35 (59.3%) was compared with the second 15 (25.4%) and the third 13 (22.0%) trimester of pregnancy using the McNemar test, with adjusted p value by Holm's method (p<0.001). No statistical difference was found when the second trimester was compared with the third trimester of pregnancy (p=0.625). Tables 2, 3 and 4 show, respectively, the results of the bivariate and multivariate analysis of the associated factors to migraine attacks in the first, second and third trimesters of pregnancy among women with MO and MA before pregnancy. Table 3 . Crude and adjusted prevalence ratios (PR), with 95% confidence interval (95% CI), according to independent variables for migraine attacks in the second trimester of pregnancy among 266 with and without aura migraine sufferers before pregnancy. Multiparity, the presence of disease during pregnancy and menstrually related MO before pregnancy had statistically significant association with the presence of migraine attacks in the first trimester of pregnancy, both after bivariate and multivariate analysis (Table 2) .
Indenpendent variables
Although in the bivariate analysis, the number of pregnancies and menstrually related MA before pregnancy showed a significant association, after Poisson's multiple regression analysis only the number of pregnancies showed a statistically significant association in the second trimester of pregnancy (Table 3) .
After multivariate analysis, Table 4 shows that only the presence of disease during pregnancy had a statistically significant association with the presence of migraine attacks in the third trimester of pregnancy, although per capita income, number of pregnancies, disease during pregnancy and menstrually related MA before pregnancy had also entered the multivariate analysis.
DISCUSSION
Although the prevalence of migraine during the woman's reproductive life is around 25.0% 1 , with 60.0% of the cases being menstually related 4 and of those 83.0% and 3.0%, respectively of MO and MA cases 12 , the present study found 38.8% of migraines sufferers before pregnancy, and 42.2% of those related to menstruation. Of the menstrually related migraine sufferers, 115 (87.8%) were MO cases, what corresponded to the findings of Miziara et al. 12 . However, with regards to MA the present study showed 16 (12.2%) women suffering from menstrually related MA before pregnancy. The differences found may be explained because, first of all it is a retrospective study and also because it is a hospital centered sample, although consecutive, which included all subjects attending the first postpartum visit. A study in which the questionnaires were applied 3 days after birth, inquiring about the prevalence of migraine (MO and MA) before pregnancy, also showed higher prevalence rates, of 29.3% 13 . During pregnancy there is a decrease or even complete cessation of migraine attacks in both, MO and MA sufferers before pregnancy 6, [13] [14] [15] . However, in MA cases the improvement and/or remission is lower during pregnancy 14, 15 , what was also demonstrated in the present study. Complete remission of MO attacks was found in 10.6%, 53.2% and 78.7%, respectively, in the first, second and third trimesters of pregnancy, with statistically significant differences between the first and second trimester and also when the second trimester was compared with the third trimester of pregnancy 6 . The present study corroborates with the literature findings 6, [13] [14] [15] , with complete remission among the MO cases in 35.4%, 76.8% and 79.3% and among those with MA in 20.7%, 58.6% e 65.5%, respectively, in the first, second and third trimesters of pregnancy, with a statistically significance difference when one compared the first with the second and third trimesters of pregnancy. This difference was not confirmed between the second and third trimesters (Table 1) , what was also not found in Maggioni et al. 13 . The course of migraine is associated with estrogen levels, with the frequency of migraine attacks tending to decline during periods of its increase or stability 2, 3, 16 . These high estrogen levels, without fluctuations, affect migraine prevalence in the majority of the women, even in those with no history of pure menstrual migraine or menstrually related migraine 6 . It is known that the corpus luteum maintains the secretion of estrogen and progesterone up to the 10 th -12 th gestational week. Later, it is the placenta that assumes these secretions that continue to increase throughout pregnancy, although they tend to stabilize between the second and third trimesters of pregnancy 6, 17 . Perhaps this is one possible explanation for the results found in the present study.
The increase in beta-endorphin levels during pregnancy, which have an antinociceptive effect, is also attributed as a possible reason for the changing in the course of migraine during this period 18 . It is also known that estrogen receptor in trigeminal ganglion neurons appear to regulate the expression of galanin and neuropeptide Y, that are involved in the nociception, in the murine estrogen cycle 16 . If these findings are confirmed in humans, this may be another explanation for the differences in migraine frequency during women's reproductive live.
In bivariate analysis, multiparity had a statistical significant association with a higher prevalence of migraine attacks during the three trimesters of pregnancy, and this association remained significant in the first and second trimesters, after multivariate analysis. In the literature search, there was a tendency for migraine attacks to increase during the third trimester of pregnancy in multiparous women 19 and to have a higher prevalence throughout pregnancy, when compared with primiparous 19, 20 . However, there are authors who did not find any significant differences in relation to parity and migraine attacks during pregnancy 6 . Multiparous have significantly more symptoms than primiparous women, including headaches 21 . Previous experiences of migraine attacks during pregnancy may generate an expectation of migraine attacks in future pregnancies 22 . This finding was demonstrated by a study that showed a decrease in somatic symptoms among primiparous women, whereas the same symptoms did not decrease or even increased in multiparous 22 . The bivariate analysis allowed to identify the explanatory variables considering as screening criteria the associations with p<0.20. Each of the three diseases reported by the women interviewed (hypertension, diabetes and urinary tract infection), would enter the multivariate analysis, with exception to diabetes in the first and second trimesters of pregnancy. But high blood pressure was the only disease that showed a significant association, in the second (p=0.004) and in the third (p<0.001) trimester of pregnancy in the bivariate analysis. However, it was not possible to enter these three diseases in the multivariate analysis because the independent variable, disease during pregnancy, contained them. In the bivariate analysis, to have disease during pregnancy in the first, second and third trimester of pregnancy showed a statistically significant association with migraine attacks during the gestational period. After multivariate analysis, this association was maintained in the first and third trimesters.
It is easy to understand how physical problems arising during pregnancy can cause anxiety and change the benefits that pregnancy brings to the course of migraine 6 . Another possible explanation for this association, especially in the third trimester, would be the fact that in both, migraine and preeclampsia cases, there are altered vasoreactivity and abnormal platelet behaviour 23, 24 , with a higher prevalence of headaches among women with preeclampsia, and in particular, of migraine 24, 25 . However, as the diagnosis were retrospective in the present study, one could not specify which type of hypertension the women had, if preeclampsia or hypertension prior to pregnancy.
In the bivariate analysis, be a menstrually related MO or MA sufferer before pregnancy, respectively in the first and second trimester of pregnancy, had a statistically significant association with migraine attacks during pregnancy. After Poisson's multiple regression analysis only
